Trexquant Investment LP

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1633445 STAMFORD, CT

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,933,585

+$3,646,843 QoQ

Shares Held

571,584

+116.5% QoQ

Ownership

0.357%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 91.03701293248237.ToString("F0")% Shared 0.ToString("F0")% None 8.962987067517634.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $93,727,758 across 14 Diagnostics & Research names. ADPT ranks #5 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	130,479	$26,094,495
2	MEDP	Medpace Holdings, Inc.	28,516	$13,693,098
3	TWST	Twist Bioscience Corp	170,107	$8,083,484
4	GH	Guardant Health, Inc.	85,901	$7,934,675
5	ADPT	Adaptive Biotechnologies Corp This page	571,584	$7,933,585
6	DHR	Danaher Corp /De/	39,489	$7,487,114
7	ICLR	Icon PLC	62,628	$6,930,414
8	WGS	GeneDx Holdings Corp.	77,350	$4,967,417

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,933,585	571,584	+116.5%	Shares	Sole	2026-05-15
2025-12-31	$4,286,742	263,962	-60.4%	Shares	Sole	2026-02-17
2025-09-30	$9,977,063	666,916	-17.7%	Shares	Sole	2025-11-14
2025-06-30	$9,443,990	810,643	+184.7%	Shares	Sole	2025-08-12
2025-03-31	$2,115,922	284,781	+53.2%	Shares	Sole	2025-05-14
2024-12-31	$1,114,278	185,868	+50.1%	Shares	Sole	2025-02-12
2022-12-31	$946,145	123,841	+688.4%	Shares	Sole	2023-02-13
2022-09-30	$111,840	15,708	+57.3%	Shares	Sole	2022-11-14
2021-09-30	$339,526	9,989	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.